Eyebright Medical Releases Its 2025 Annual Report and Sustainability Report
Innovation Drives Strong Results, While Global Expansion and ESG Practices Progress Steadily HONG KONG, April 27, 2026 /PRNewswire/ -- Eyebright Medical Technology (Beijing) Co., Ltd. ("Eyebright Medical", "the Company", Stock Code: 688050.SH,...
Eyebright Medical Published its 2024 Environmental, Social and Governance Report
Commitment to Sustainable Development, Social Responsibility, and Corporate Governance HONG KONG, April 23, 2025 /PRNewswire/ -- Eyebright Medical Technology (Beijing) Co., Ltd. ("Eyebright Medical", the "Company", Stock Code: 688050.SH, together...
Eyebright Medical Receives NMPA Class III Certificate for its Phakic Intraocular Lens
HONG KONG, Jan. 7, 2025 /PRNewswire/ -- Eyebright Medical Technology (Beijing) Co., Ltd. ("Eyebright Medical", the "Company", Stock Code: 688050.SH, together with its subsidiaries collectively known as the "Group") is proud to announce that our...